Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Tanoto Tan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Immunotherapy Advances|August 28, 2023
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole bloodMeiyin Lin, Sebastian Chakrit Bhakdi, Damien Tan, et al.
Biomaterials|March 5, 2025
In vitro integration of a functional vasculature to model endothelial regulation of chemotherapy and T-cell immunotherapy in liver cancerJyothsna Vasudevan, Ragavi Vijayakumar, Jose Antonio Reales-Calderon, et al.
Journal of Virology|September 19, 2008
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoireAnthony Tanoto Tan, Elisabetta Loggi, Carolina Boni, et al.
Cell Host & Microbe|May 4, 2020
A Dynamic Immune Response Shapes COVID-19 ProgressionEugenia Ziying Ong, Yvonne Fu Zi Chan, Wan Ying Leong, et al.
Cellular & Molecular Immunology|September 4, 2023
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapyQi Chen, Adeline Chia, Shou Kit Hang, et al.
Hepatology Communications|December 22, 2021
Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCCAnthony Tanoto Tan, Fanping Meng, Jiehua Jin, et al.
Gastroenterology|February 4, 2019
Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for ImmunotherapyAnthony Tanoto Tan, Ninghan Yang, Thinesh Lee Krishnamoorthy, et al.
Hepatology International|December 1, 2021
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trialFanping Meng, Jinfang Zhao, Anthony Tanoto Tan, et al.
Cell Reports|August 14, 2021
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individualsDaniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Immunotherapy Advances|August 28, 2023
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole bloodMeiyin Lin, Sebastian Chakrit Bhakdi, Damien Tan, et al.
Biomaterials|March 5, 2025
In vitro integration of a functional vasculature to model endothelial regulation of chemotherapy and T-cell immunotherapy in liver cancerJyothsna Vasudevan, Ragavi Vijayakumar, Jose Antonio Reales-Calderon, et al.
Journal of Virology|September 19, 2008
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoireAnthony Tanoto Tan, Elisabetta Loggi, Carolina Boni, et al.
Cell Host & Microbe|May 4, 2020
A Dynamic Immune Response Shapes COVID-19 ProgressionEugenia Ziying Ong, Yvonne Fu Zi Chan, Wan Ying Leong, et al.
Cellular & Molecular Immunology|September 4, 2023
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapyQi Chen, Adeline Chia, Shou Kit Hang, et al.
Hepatology Communications|December 22, 2021
Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCCAnthony Tanoto Tan, Fanping Meng, Jiehua Jin, et al.
Gastroenterology|February 4, 2019
Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for ImmunotherapyAnthony Tanoto Tan, Ninghan Yang, Thinesh Lee Krishnamoorthy, et al.
Hepatology International|December 1, 2021
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trialFanping Meng, Jinfang Zhao, Anthony Tanoto Tan, et al.
Cell Reports|August 14, 2021
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individualsDaniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, et al.
Pageof 2